Point-of-Care Industry Expert, Angelo Campano, Joins OptimizeRx Executive Leadership as Senior Vice President and Principal of Agency Channels
Campano will be responsible for driving the strategic growth and expansion of
“Angelo is an incredibly well-respected thought leader, innovator and strategist in point-of-care solutions, and we are honored to have him join our team,” said
“As we evolve our platform to meet the growing need for connectivity and even greater focus on specialty medications, Angelo’s expertise will help us drive even more growth and accelerate innovation in the collaboration between healthcare stakeholders.”
The
The company’s point-of-care expansions this year include partnerships with Change Healthcare and Epion. It has also added point-of-dispense touchpoints through a new partnership with Higi, which represents innovative new modes of delivery for healthcare advertising agencies who are looking to serve valuable support content on behalf of life science organizations.
“I am excited to join the
Campano has been a trailblazer in innovation and leadership in electronic health record (EHR) workflow and hub services. Prior to joining
Campano received a bachelor’s degree in bioinformatics from
About
For more information, follow the company on Twitter, LinkedIn or visit www.optimizerx.com.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
OptimizeRx Contact
Tel (248) 651-6568 (x807)
dbaker@optimizerx.com
Media Relations Contact
Tel (754) 245-7070
malejandra@optimizerx.com
Investor Relations Contact
Tel (949) 432-7557
oprx@cma.team
Source: OptimizeRx Corporation